Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts

Bryan A. Moore, Sadie Aznavoorian, Jeffrey A. Engler, L. Windsor

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

There is a growing body of evidence that implicates matrix metalloproteinases (MMPs) as major players in numerous diseased conditions. The articular cartilage degradation that is characteristic of rheumatoid arthritis (RA) is believed to be mediated by the collagenase subfamily of matrix metalloproteinases. The preference of collagenase-3 (CL-3) for collagen type II makes it a likely candidate in the turnover of articular cartilage and a potential target for drug development. In this study, RA synovial membrane tissue was shown to express CL-3 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) and protein by immunohistochemistry. Fibroblasts isolated and cultured from RA synovial membrane tissue were induced to express CL-3 mRNA. CL-3 mRNA was detected after PMA treatment in 16 of the 18 RA synovial membrane fibroblast cell lines established for this study. These fibroblasts also expressed mRNA for collagenase-1 (CL-1, MMP-1), membrane type-1 matrix metalloproteinase, gelatinase A, gelatinase B, stromelysin-1, stromelysin-2, TIMP-1, and TIMP-2. They were further shown to express CL-1 mRNA constitutively and CL-3 mRNA only after stimulation with PMA, IL-1, TGF-β1, TNF-α, or IL-6 with IL-6sR. These fibroblasts also expressed after induction both CL-1 and CL-3 at the protein level as determined by Western blot analyses and immunofluorescence. Copyright (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)307-318
Number of pages12
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1502
Issue number2
DOIs
StatePublished - Oct 18 2000

Fingerprint

Matrix Metalloproteinase 13
Rheumatoid Arthritis
Fibroblasts
Messenger RNA
Synovial Membrane
Articular Cartilage
Matrix Metalloproteinases
Matrix Metalloproteinase 10
Matrix Metalloproteinase 14
Tissue Inhibitor of Metalloproteinase-2
Matrix Metalloproteinase 3
Matrix Metalloproteinase 1
Tissue Inhibitor of Metalloproteinase-1
Membranes
Collagen Type II
Matrix Metalloproteinase 2
Matrix Metalloproteinase 9
Collagenases
Reverse Transcriptase Polymerase Chain Reaction
Interleukin-1

Keywords

  • Collagenase-3
  • Matrix metalloproteinase
  • Synovial fibroblast

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Biophysics

Cite this

Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. / Moore, Bryan A.; Aznavoorian, Sadie; Engler, Jeffrey A.; Windsor, L.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1502, No. 2, 18.10.2000, p. 307-318.

Research output: Contribution to journalArticle

Moore, Bryan A. ; Aznavoorian, Sadie ; Engler, Jeffrey A. ; Windsor, L. / Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. In: Biochimica et Biophysica Acta - Molecular Basis of Disease. 2000 ; Vol. 1502, No. 2. pp. 307-318.
@article{12a23e6e84cc4f01960126c2aa524682,
title = "Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts",
abstract = "There is a growing body of evidence that implicates matrix metalloproteinases (MMPs) as major players in numerous diseased conditions. The articular cartilage degradation that is characteristic of rheumatoid arthritis (RA) is believed to be mediated by the collagenase subfamily of matrix metalloproteinases. The preference of collagenase-3 (CL-3) for collagen type II makes it a likely candidate in the turnover of articular cartilage and a potential target for drug development. In this study, RA synovial membrane tissue was shown to express CL-3 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) and protein by immunohistochemistry. Fibroblasts isolated and cultured from RA synovial membrane tissue were induced to express CL-3 mRNA. CL-3 mRNA was detected after PMA treatment in 16 of the 18 RA synovial membrane fibroblast cell lines established for this study. These fibroblasts also expressed mRNA for collagenase-1 (CL-1, MMP-1), membrane type-1 matrix metalloproteinase, gelatinase A, gelatinase B, stromelysin-1, stromelysin-2, TIMP-1, and TIMP-2. They were further shown to express CL-1 mRNA constitutively and CL-3 mRNA only after stimulation with PMA, IL-1, TGF-β1, TNF-α, or IL-6 with IL-6sR. These fibroblasts also expressed after induction both CL-1 and CL-3 at the protein level as determined by Western blot analyses and immunofluorescence. Copyright (C) 2000 Elsevier Science B.V.",
keywords = "Collagenase-3, Matrix metalloproteinase, Synovial fibroblast",
author = "Moore, {Bryan A.} and Sadie Aznavoorian and Engler, {Jeffrey A.} and L. Windsor",
year = "2000",
month = "10",
day = "18",
doi = "10.1016/S0925-4439(00)00056-9",
language = "English (US)",
volume = "1502",
pages = "307--318",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts

AU - Moore, Bryan A.

AU - Aznavoorian, Sadie

AU - Engler, Jeffrey A.

AU - Windsor, L.

PY - 2000/10/18

Y1 - 2000/10/18

N2 - There is a growing body of evidence that implicates matrix metalloproteinases (MMPs) as major players in numerous diseased conditions. The articular cartilage degradation that is characteristic of rheumatoid arthritis (RA) is believed to be mediated by the collagenase subfamily of matrix metalloproteinases. The preference of collagenase-3 (CL-3) for collagen type II makes it a likely candidate in the turnover of articular cartilage and a potential target for drug development. In this study, RA synovial membrane tissue was shown to express CL-3 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) and protein by immunohistochemistry. Fibroblasts isolated and cultured from RA synovial membrane tissue were induced to express CL-3 mRNA. CL-3 mRNA was detected after PMA treatment in 16 of the 18 RA synovial membrane fibroblast cell lines established for this study. These fibroblasts also expressed mRNA for collagenase-1 (CL-1, MMP-1), membrane type-1 matrix metalloproteinase, gelatinase A, gelatinase B, stromelysin-1, stromelysin-2, TIMP-1, and TIMP-2. They were further shown to express CL-1 mRNA constitutively and CL-3 mRNA only after stimulation with PMA, IL-1, TGF-β1, TNF-α, or IL-6 with IL-6sR. These fibroblasts also expressed after induction both CL-1 and CL-3 at the protein level as determined by Western blot analyses and immunofluorescence. Copyright (C) 2000 Elsevier Science B.V.

AB - There is a growing body of evidence that implicates matrix metalloproteinases (MMPs) as major players in numerous diseased conditions. The articular cartilage degradation that is characteristic of rheumatoid arthritis (RA) is believed to be mediated by the collagenase subfamily of matrix metalloproteinases. The preference of collagenase-3 (CL-3) for collagen type II makes it a likely candidate in the turnover of articular cartilage and a potential target for drug development. In this study, RA synovial membrane tissue was shown to express CL-3 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR) and protein by immunohistochemistry. Fibroblasts isolated and cultured from RA synovial membrane tissue were induced to express CL-3 mRNA. CL-3 mRNA was detected after PMA treatment in 16 of the 18 RA synovial membrane fibroblast cell lines established for this study. These fibroblasts also expressed mRNA for collagenase-1 (CL-1, MMP-1), membrane type-1 matrix metalloproteinase, gelatinase A, gelatinase B, stromelysin-1, stromelysin-2, TIMP-1, and TIMP-2. They were further shown to express CL-1 mRNA constitutively and CL-3 mRNA only after stimulation with PMA, IL-1, TGF-β1, TNF-α, or IL-6 with IL-6sR. These fibroblasts also expressed after induction both CL-1 and CL-3 at the protein level as determined by Western blot analyses and immunofluorescence. Copyright (C) 2000 Elsevier Science B.V.

KW - Collagenase-3

KW - Matrix metalloproteinase

KW - Synovial fibroblast

UR - http://www.scopus.com/inward/record.url?scp=0034684283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034684283&partnerID=8YFLogxK

U2 - 10.1016/S0925-4439(00)00056-9

DO - 10.1016/S0925-4439(00)00056-9

M3 - Article

C2 - 11040455

AN - SCOPUS:0034684283

VL - 1502

SP - 307

EP - 318

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 2

ER -